<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We gave a regimen of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and antithymocyte globulin (CY/ATG) to six patients with early stage severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) transplanted with marrow from alternative donors </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients engrafted and are alive with durable engraftment at a median follow-up of 406 days </plain></SENT>
<SENT sid="2" pm="."><plain>The CY/ATG regimen may be sufficient in Korean patients with early stage SAA receiving marrow transplantation from alternative donors </plain></SENT>
</text></document>